ranbaxy laboratories ltd emerging markets boosted profit in second quarter ranbaxy laboratories ltd said second quarter consolidated net profit more than doubled helped by performance in emerging markets and on foreign exchange gains the largest indian pharmaceutical company by sales also forecast a strong second half driven by product launches "over products are going to be launched in various markets around the world in the second half of the year " said chief executive and managing director malvinder mohan singh net rose to billion rupees &# million from billion rupees in the year earlier quarter the appreciation of the rupee which gained against the dollar in the quarter meant the company spent less in servicing overseas debt excluding these foreign exchange gains profit would have been billion rupees the company said sales rose to billion rupees shares rose on the bombay stock exchange yesterday 
